MariMed Inc. (MRMD)

OTCMKTS · Delayed Price · Currency is USD
0.0878
+0.0016 (1.86%)
At close: Apr 28, 2026
-18.70%
Market Cap 35.02M
Revenue (ttm) 159.83M
Net Income (ttm) -14.48M
Shares Out 398.91M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,278,860
Average Volume 1,012,505
Open 0.0890
Previous Close 0.0862
Day's Range 0.0800 - 0.0955
52-Week Range 0.0641 - 0.2300
Beta 1.15
RSI 64.88
Earnings Date May 13, 2026

About MariMed

MariMed Inc. engages in cultivation, production, and selling of branded cannabis products in the United States. The company sells cannabis flower, vapes, and concentrates under the Nature’s Heritage brand; and cannabis fruit chews that delivers better sleep, pain relief, stress relief, and others under Betty’s Eddies brand. It offers soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; cannabis-infused hydrating drink mix for discrete and on-the-go consumption under Vibations brand; and flower, vapes, and edibles under ... [Read more]

Sector Healthcare
Founded 2011
Employees 923
Stock Exchange OTCMKTS
Ticker Symbol MRMD
Full Company Profile

Financial Performance

In 2025, MariMed's revenue was $159.83 million, an increase of 1.34% compared to the previous year's $157.71 million. Losses were -$14.48 million, 16.2% more than in 2024.

Financial Statements

News

MariMed Announces First Quarter 2026 Earnings Date

NORWOOD, Mass., April 15, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today...

13 days ago - GlobeNewsWire

MariMed Earnings Call Transcript: Q4 2025

Revenue grew 7% to $160M in 2025, with strong wholesale gains and expanded brand reach via licensing. Margin discipline, positive cash flow, and a strengthened balance sheet position the company for further growth, despite ongoing price compression in mature markets.

6 weeks ago - Transcripts

MariMed Reports Fourth Quarter and Full Year 2025 Earnings

NORWOOD, Mass., March 11, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, to...

6 weeks ago - GlobeNewsWire

MariMed Extends Series B Preferred Stock Obligation Through 2031, Strengthening Capital Structure

NORWOOD, Mass., March 02, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today...

2 months ago - GlobeNewsWire

MariMed Announces Fourth Quarter and Full Year 2025 Earnings Date

NORWOOD, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today ...

2 months ago - GlobeNewsWire

MariMed Statement on Historic Rescheduling of Cannabis

NORWOOD, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator committed to improving lives every day, issued the followi...

4 months ago - GlobeNewsWire

Veterans Healing Journey Becomes Soundtrack of Thrive Dispensaries

Veteran and customer of Thrive Dispensary in Anna, IL writes song of appreciation for Thrive and to raise visibility for veteran's org FreedomSingsUSA.

5 months ago - GlobeNewsWire

MariMed's Betty's Eddies™ Introduces New Limited-Edition Winter Seasonal Cranberry Orange Fruit Chew, Bundle Up Betty's

Bundle Up Betty's Uses Real Cranberry, Orange, and Warming Spices in Each Fruit Chew to Deliver Cozy Winter Wind-Downs Bundle Up Betty's Uses Real Cranberry, Orange, and Warming Spices in Each Fruit C...

5 months ago - GlobeNewsWire

MariMed Earnings Call Transcript: Q3 2025

Q3 saw sequential growth in wholesale and retail revenue, with strong brand performance in core markets and a shift toward wholesale driving margin stability. Expansion into hemp and new licensing deals support long-term growth, while cost discipline improved cash flow and EBITDA.

6 months ago - Transcripts

MariMed Reports Third Quarter 2025 Earnings

NORWOOD, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, tod...

6 months ago - GlobeNewsWire

MariMed To Launch Hemp-Derived THC Products, Introducing Its Top-Selling Brands to New Markets and Customers

NORWOOD, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, today announced ma...

6 months ago - GlobeNewsWire

MariMed's InHouse Brand Again Supports Veterans Facing Housing Challenges With Second Annual Help on the Homefront Campaign

NORWOOD, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- InHouse™ announced today the launch of its second annual Help on the Homefront campaign, a philanthropic effort that provides veterans the chance to w...

7 months ago - GlobeNewsWire

MariMed Announces Third Quarter 2025 Earnings Date

MariMed will report its third quarter 2025 financial results on November 5, 2025 and conduct its analyst conference call on November 6, 2025, at 8am ET.

7 months ago - GlobeNewsWire

MariMed's Betty's Eddies Spreads Importance of Cancer Screening Education and Awareness through Partnership with Keep A Breast Foundation

NORWOOD, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Betty's Eddies™ announced its third annual collaboration with the Keep A Breast Foundation (“KAB”), furthering its commitment to breast cancer awaren...

7 months ago - GlobeNewsWire

MariMed Earnings Call Transcript: Q2 2025

Sequential revenue and EBITDA growth were driven by strong wholesale and retail performance, especially in Massachusetts and Delaware, while new market entries and product innovation support future expansion. Missouri operations are under review, and the balance sheet remains healthy.

9 months ago - Transcripts

MariMed Reports Second Quarter 2025 Earnings

NORWOOD, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, tod...

9 months ago - GlobeNewsWire

MariMed's Products to Enter Pennsylvania Market Through a Management Services and Licensing Agreement with TILT Holdings

NORWOOD, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, today announced a ...

9 months ago - GlobeNewsWire

CORRECTION -- MariMed Expands Access to Top-Selling Betty's Eddies Brand in Maine

NORWOOD, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD) today announced a licensing agreement with The Stoned Moose, LLC (“The Stoned Moose”...

10 months ago - GlobeNewsWire

MariMed Expands Access to Top-Selling Betty's Eddies Brand in Maine

NORWOOD, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD) today announced a licensing agreement with The Stoned Moose, LLC (“The Stoned Moose”...

10 months ago - GlobeNewsWire

MariMed Announces Second Quarter 2025 Earnings Date

NORWOOD, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it w...

10 months ago - GlobeNewsWire

MariMed Statement Regarding the Commencement of Adult-Use Cannabis Sales in Delaware on August 1st

NORWOOD, Mass., July 01, 2025 (GLOBE NEWSWIRE) -- Following today's announcement that Delaware will commence adult-use sales of cannabis, MariMed CEO Jon Levine released the following statement: “We a...

10 months ago - GlobeNewsWire

MariMed's Premium Nature's Heritage Brand Enters Functional Mushroom Market Launching Plant-Based MycroDose

NORWOOD, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD), the company behind the award-winning flower and concentrate brand, Nature's Heritage™, continued to...

11 months ago - GlobeNewsWire

MariMed Earnings Call Transcript: Q1 2025

Q1 2025 revenue was flat year-over-year at $38 million, with wholesale growth offsetting retail softness and margin pressure from price compression. Adjusted EBITDA declined to $2.6 million, and Q2 revenue is expected to rise by high single digits quarter-over-quarter.

1 year ago - Transcripts

MariMed Reports First Quarter 2025 Earnings

NORWOOD, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, toda...

1 year ago - GlobeNewsWire

MariMed Announces First Quarter 2025 Earnings Date

NORWOOD, Mass., April 08, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it ...

1 year ago - GlobeNewsWire